within Pharmacolibrary.Drugs.ATC.A;

model A10BB12
  extends Pharmacokinetic.Models.PK_2C_enteral(
    weight         = 70,
    F              = 1,
    Cl             = 1.0716666666666667e-05,
    adminDuration  = 600,
    adminMass      = 2 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.0088,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0050999999999999995,
    Tlag           = 10.020000000000001,            
    Vdp             = 0.0181,
    k12             = 1.78,
    k21             = 1.78
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>A10BB12</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Glimepiride is a second-generation sulfonylurea antidiabetic drug used for the treatment of type 2 diabetes mellitus. It stimulates pancreatic beta cells to release insulin, thereby lowering blood glucose levels. Glimepiride is approved and widely used in clinical practice today.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in healthy adult volunteers (both sexes), oral administration, single 2 mg dose.</p><h4>References</h4><ol><li><p>Kim, EY, et al., &amp; Lee, K (2015). Effect of Piperazine Dithioctate on the Oral Pharmacokinetics of Glimepiride in Rats. <i>Biological &amp; pharmaceutical bulletin</i> 38(8) 1161–1168. DOI:<a href=\"https://doi.org/10.1248/bpb.b15-00044\">10.1248/bpb.b15-00044</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/26235578/\">https://pubmed.ncbi.nlm.nih.gov/26235578</a></p></li><li><p>Viana, ALM, et al., &amp; de Araújo Paula, FB (2018). Pharmacokinetics and pharmacodynamics of glimepiride polymorphs. <i>International journal of pharmaceutics</i> 553(1-2) 272–280. DOI:<a href=\"https://doi.org/10.1016/j.ijpharm.2018.10.050\">10.1016/j.ijpharm.2018.10.050</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/30359686/\">https://pubmed.ncbi.nlm.nih.gov/30359686</a></p></li><li><p>Niemi, M, et al., &amp; Neuvonen, PJ (2000). Effect of rifampicin on the pharmacokinetics and pharmacodynamics of glimepiride. <i>British journal of clinical pharmacology</i> 50(6) 591–595. DOI:<a href=\"https://doi.org/10.1046/j.1365-2125.2000.00295.x\">10.1046/j.1365-2125.2000.00295.x</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/11136298/\">https://pubmed.ncbi.nlm.nih.gov/11136298</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end A10BB12;
